ARDX Stock Analysis: Buy, Sell, or Hold?

ARDX - Ardelyx, Inc.

PHARMACEUTICAL PREPARATIONS
$6.23
-0.23 (-3.56%) ▼
5d: -8.11%
30d: -0.8%
90d: -9.32%
HOLD
LOW Confidence
Protect Your ARDX Gains
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: Apr 30, 2026 0d
Smart Money Accumulation

ARDX is down 8.1% this week, but smart money is accumulating calls. Top strike: $7 2026-06-18 with 10,787 OI. Call ratio: 97% View Scanner →

Strength: 8.8/10

Get Alerted When ARDX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: ARDX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$16.53
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$10.26
39.3% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.9x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: ARDX is currently trading at $6.23, which is considered fair relative to its 30-day fair value range of $5.98 to $6.75. From a valuation perspective, the stock is trading at a discount (Forward PE: 12.1) compared to its historical average (22.9). Remarkably, the market is currently pricing in an annual earnings decline of 19.2% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, ARDX is in a strong uptrend. The price is currently testing key support at $6.17. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.6% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $16.33 (+162.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $5.98 - $6.75
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 67.6%

Protect Your Profits

Holding ARDX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.6%)
  • BULLISH: Trading 162.2% below Wall St target ($16.33)
  • CAUTION: Recommendation downgraded due to -8.1% 5-day decline

Trading Range Analysis

30-Day Trading Range $5.98 - $6.75
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $6.17
Resistance Level $7.43
Current Trend Strong Uptrend
Technical data as of May 15, 2026

Fundamental Context

Forward P/E (Next Year Est.) 12.09
Wall Street Target $16.33 (+162.2%)
Revenue Growth (YoY) 27.5%
Profit Margin -13.6%
Valuation Discount vs History -19.2% cheaper
PE vs Historical 12.1 vs 22.9 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -19.2% (market-implied from PE analysis)
1-Year Target $5.61 (-10%)
2-Year Target $5.05 (-19%)
3-Year Target $4.54 (-27%)
3-Yr Target (if PE normalizes) (PE: 12→23) $8.60 (+38%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.1 to 22.9
Stabilization Target: $11.80 (+89.3%)
PE Expansion Potential: +89.3%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: May 18, 2026 9:19 AM ET
Data refreshes hourly during market hours. Next update: 10:19 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
1
Buys
14
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Raab SELL 41666 shares 2026-03-16
David M Mott BUY 333333 shares 2026-02-20
Susan Hohenleitner SELL 2033 shares 2026-02-20

Unlock Insider Activity

See real-time buying/selling by company executives for ARDX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
29 analysts
$90 60 BUY
CYTK
Cytokinetics Inc
STRONG BUY
21 analysts
$105 62 BUY
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$101 58 HOLD
BHVN
Biohaven Pharmaceutical …
STRONG BUY
16 analysts
$22 57 HOLD
RVMD
Revolution Medicines Inc
STRONG BUY
12 analysts
$181 61 BUY

Advanced ARDX Option Strategies

Professional options setups generated by AI based on today's ARDX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ARDX

ARDX Technical Chart ARDX Price Prediction ARDX Earnings Date ARDX Investment Advisor ARDX Fair Price Analyzer ARDX Options Advisor ARDX Options Chain ARDX Options Analysis ARDX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals